Qiagen acquires Molecular Staging assets
Dutch biotech firm Qiagen has announced the acquisition of key assets of Molecular Staging (MSI), which includes the Whole Genome Amplification (WGA) technology, designed to eliminate limitations created by scarce quantities of DNA samples.